Synonyms: VIS-649 | VIS649
Compound class:
Antibody
Comment: Sibeprenlimab (VIS-649) is a fully humanized IgG2κ monoclonal antibody that targets the B-cell growth factor APRIL (TNFSF13) [1,4]. The antibody binds with high affinity to human trimeric APRIL, and potently blocks APRIL binding to its receptors TACI (transmembrane activator and CAML interactor) and BCMA (B-cell maturation antigen). It was developed by Visterra for anti-inflammatory potential.
|
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
11575 | sibeprenlimab |
Synonyms ![]() |
VIS-649 | VIS649 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 1144 |
Other databases | |
GtoPdb PubChem SID | 472319224 |
Search PubMed clinical trials | sibeprenlimab |
Search PubMed titles | sibeprenlimab |
Search PubMed titles/abstracts | sibeprenlimab |